These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3463621

  • 1. [Comparative study of 3 markers in ovarian cancer: CA 125, CA 19,9 and CEA].
    Vigné E, Krebs B, Khater R, Mira R, Boublil JL, Jourlait A, Frenay M, Namer M.
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(5):609-13. PubMed ID: 3463621
    [Abstract] [Full Text] [Related]

  • 2. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
    Schröck R, Hafter R, Schmid L, Babic R, Ulm K, Gössner W, Graeff H.
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
    Lahousen M.
    Wien Klin Wochenschr; 1986 May 16; 98(10):319-25. PubMed ID: 3460273
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prediction of clinical course and recurrence of human ovarian cancer by several serum tumor markers.
    Kikuchi Y, Kita T, Iwano I, Kuki E, Oomori K, Kizawa I.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan 16; 41(1):69-76. PubMed ID: 2926196
    [Abstract] [Full Text] [Related]

  • 7. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
    Sevelda P, Wagner G.
    Wien Klin Wochenschr; 1987 Nov 06; 99(21):768-70. PubMed ID: 3480655
    [Abstract] [Full Text] [Related]

  • 8. [Tumor marker combination versus second-look operation in ovarian cancer].
    Lahousen M, Stettner H, Pürstner P, Pickel H.
    Zentralbl Gynakol; 1990 Nov 06; 112(9):561-6. PubMed ID: 2378187
    [Abstract] [Full Text] [Related]

  • 9. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, van der Zee AG.
    Gynecol Oncol; 2000 Jul 06; 78(1):16-20. PubMed ID: 10873403
    [Abstract] [Full Text] [Related]

  • 10. [Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer].
    Meier W, Stieber P, Fateh-Moghadam A, Eiermann W, Hepp H.
    Geburtshilfe Frauenheilkd; 1988 May 06; 48(5):331-3. PubMed ID: 3165078
    [Abstract] [Full Text] [Related]

  • 11. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C, von Lieven H, Mulders M, Rowold J, Stracke H, Müller H, Grebe SF, Schatz H.
    Wien Klin Wochenschr; 1985 Dec 06; 97(23):873-9. PubMed ID: 3878042
    [Abstract] [Full Text] [Related]

  • 12. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT.
    Ann Clin Lab Sci; 1989 Dec 06; 19(1):17-26. PubMed ID: 2916833
    [Abstract] [Full Text] [Related]

  • 13. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
    Yuan CC, Ng HT, Tsai LC, Jeng FS, Yeh SH, Tsai YC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug 06; 20(3):190-7. PubMed ID: 3480793
    [Abstract] [Full Text] [Related]

  • 14. [Tumor markers in epithelial carcinoma of the ovary].
    Cottini M, Carnino F, Iskra L, Rapisarda V, Mossetti C.
    Minerva Ginecol; 1986 Jun 06; 38(6):479-84. PubMed ID: 3461313
    [No Abstract] [Full Text] [Related]

  • 15. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
    Kivinen S, Kuoppala T, Leppilampi M, Vuori J, Kauppila A.
    Obstet Gynecol; 1986 Apr 06; 67(4):468-72. PubMed ID: 3008051
    [Abstract] [Full Text] [Related]

  • 16. CA 125 as a marker in epithelial ovarian cancer: Alone and in comparison with CEA.
    Bhatavdekar JM, Shah NG, Trivedi SN, Karelia NH, Balar DB, Patel TB.
    Indian J Cancer; 1987 Dec 06; 24(4):222-31. PubMed ID: 3505511
    [No Abstract] [Full Text] [Related]

  • 17. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y, Fujiwara H, Akagaki E, Hirota K, Kono M, Irie T, Miura S, Okudaira Y.
    Gan To Kagaku Ryoho; 1986 Jan 06; 13(1):46-52. PubMed ID: 3455806
    [Abstract] [Full Text] [Related]

  • 18. [Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer].
    Gadducci A, Ferdeghini M, Bartolini T, Facchini V, Bianchi R, Fioretti P.
    Ann Ostet Ginecol Med Perinat; 1986 Jan 06; 107(4):193-9. PubMed ID: 3467641
    [No Abstract] [Full Text] [Related]

  • 19. [Experiences with the tumor markers Ca 125 and plasma ribonuclease in ovarian cancer].
    Lücke R, Benz R, Kraus H.
    Geburtshilfe Frauenheilkd; 1987 Dec 06; 47(12):846-9. PubMed ID: 3481339
    [Abstract] [Full Text] [Related]

  • 20. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
    Göcze P, Vahrson H.
    Orv Hetil; 1993 Apr 25; 134(17):915-8. PubMed ID: 8479736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.